Tyrosine Kinase Inhibitor Sunitinib Targets the Vasculature of Clear Cell Renal Cell Carcinoma: A Histological and Immunocytochemical Study of Treatment Effect

被引：0
|
作者：
Huang, J. [1 ]
Thomas, A. [1 ]
Simmerman, K. [1 ]
Sercia, L. [1 ]
Magi-Galluzzi, C. [1 ]
Campbell, S. [1 ]
Rini, B. [1 ]
Zhou, M. [1 ]
机构：
[1] Cleveland Clin, Cleveland, OH 44106 USA
来源：
LABORATORY INVESTIGATION | 2010年 / 90卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
873
引用
收藏
页码：197A / 197A
页数：1
相关论文
共 50 条
  • [31] Epithelial-mesenchymal transition as a mechanism of the acquired tyrosine kinase inhibitor resistance in clear cell renal cell carcinoma
    Hwang, Sang
    Go, Heounjeong
    Park, Ja-Min
    Yoon, Sun Young
    Lee, Jae-Lyun
    Jeong, Se Un
    Cho, Yong Mee
    MODERN PATHOLOGY, 2018, 31 : 351 - 351
  • [32] When tyrosine kinase inhibitor sunitinib can be discontinued in metastatic renal cell carcinoma to pancreas: A case report
    Sbitti Y.
    Debbagh A.
    Slimani K.
    Mahi M.
    Errihani H.
    Ichou M.
    Journal of Medical Case Reports, 12 (1)
  • [33] MiR-99b-5p expression and response to tyrosine kinase inhibitor treatment in clear cell renal cell carcinoma patients
    Lukamowicz-Rajska, Magdalena
    Mittmann, Christiane
    Prummer, Michael
    Zhong, Qing
    Bedke, Jens
    Hennenlotter, Joerg
    Stenzl, Arnulf
    Mischo, Axel
    Bihr, Svenja
    Schmidinger, Manuela
    Vogl, Ursula
    Blume, Iris
    Karlo, Christoph
    Schraml, Peter
    Moch, Holger
    ONCOTARGET, 2016, 7 (48) : 78433 - 78447
  • [34] A Study on the Expression of Vascular Epidermal Growth Factor and Angiotensin II in Clear Cell Renal Cell Carcinoma and Sunitinib in Renal Cell Treatment
    Che, Xiaoling
    Zhou, Kai
    Ren, Lili
    Xu, Song
    Cheng, Wen
    Zhang, Zhengyu
    Zhou, Wenquan
    Ge, Jingping
    Zhang, Zhihong
    Fu, Dian
    ANALYTICAL AND QUANTITATIVE CYTOPATHOLOGY AND HISTOPATHOLOGY, 2018, 40 (03): : 116 - 124
  • [35] MCT INHIBITION SYNERGIZES WITH TYROSINE KINASE AND MTOR INHIBITOR TREATMENT IN RENAL CELL CARCINOMA
    Jambunathan, Bhaghyasree
    Dergham, Abdo
    Bhattacharjee, Sayani
    Wynn, Rebecca
    Sindhwani, Puneet
    Petros, Firas
    Nadiminty, Nagalakshmi
    JOURNAL OF UROLOGY, 2022, 207 (05): : E702 - E702
  • [36] Pazopanib The Newest Tyrosine Kinase Inhibitor for the Treatment of Advanced or Metastatic Renal Cell Carcinoma
    Keisner, Sidney V.
    Shah, Sachin R.
    DRUGS, 2011, 71 (04) : 443 - 454
  • [37] Tyrosine kinase inhibitor as adjuvant treatment of renal cell carcinoma: 1 versus 3
    Penel, Nicolas
    BULLETIN DU CANCER, 2017, 104 (09) : 705 - 706
  • [38] Pazopanib: The newest tyrosine kinase inhibitor for the treatment of advanced or metastatic renal cell carcinoma
    Keisner S.V.
    Shah S.R.
    Drugs, 2011, 71 (4) : 443 - 454
  • [39] Antigenic targets in clear cell renal cell carcinoma
    Schindler, Nicholas R.
    Braun, David A.
    KIDNEY CANCER, 2023, 7 (01) : 81 - 91
  • [40] Emerging Targets in Clear Cell Renal Cell Carcinoma
    Chen, Yu-Wei
    Rini, Brian, I
    Beckermann, Kathryn E.
    CANCERS, 2022, 14 (19)
12345